Miller Jeffrey W, Vu Dien N, Chai Paul J, Kreutzer Janet H, John J Blaine, Vener David F, Jacobs Jeffrey P
Division of Pediatric Cardiac Anesthesiology, Congenital Heart Institute of Florida, Tampa, USA.
Paediatr Anaesth. 2013 Nov;23(11):980-8. doi: 10.1111/pan.12261. Epub 2013 Sep 19.
A central venous catheter located in the jugular or subclavian vein provides rapid, reliable vascular access for pediatric heart surgery. However, intravascular catheters are associated with vessel injury. Stenosis or thrombosis of central veins in the upper body can lead to 'superior vena cava syndrome' with markedly elevated venous pressures in the head and neck, causing facial swelling and headaches. This complication may be especially serious for patients with superior cavopulmonary (Glenn) or total cavopulmonary (Fontan) circulation. The authors hypothesized that upper body central line placement would be associated with a low risk of venous thrombosis or stenosis.
A three-year retrospective review of infant and univentricular cardiac procedures at a single institution was performed. Two hundred and thirty-five consecutive cardiac surgical patients <1 year of age or undergoing palliation for univentricular cardiac anatomy up to five years of age during January 2010 to December 2012 were included in this study. Upper body central lines are routinely placed by the anesthesiologist after induction of anesthesia for pediatric cardiac surgery at the study institution. The major exception is existing central venous access via an umbilical vein or femoral vein. Patients <2 years of age received a 4.0-French, 5-cm double-lumen central line [Cook Medical polyurethane, no antibiotic or heparin coating]. Those over two years of age received a 5.0-French, 8-cm triple lumen central line [Cook Medical polyurethane, no antibiotic or heparin coating]. A retrospective review of charts, hospital reports, echocardiographic studies, and cardiac catheterization studies was performed.
The combined population of infants <1 year of age and patients <5 years of age with functional univentricular hearts totaled 235 patients who underwent 261 cardiac surgical operations. In this cohort of 261 cases, 171 size 4.0 or 5.0-French upper body central lines were inserted. A total of 158 right internal jugular vein catheters were placed. Two left internal jugular lines, two left subclavian lines, and nine right subclavian lines were placed in this population after failure to obtain right internal jugular access. Due to the small sample size (N = 13), the central lines not placed in the right internal jugular vein were excluded from further review. Two cases with right internal jugular venous lines were excluded due to death (without known stenosis or thrombosis) with the line in place. Twenty-three size 4.0- or 5.0-French right internal jugular central venous lines were placed in patients over one year of age (range 1.1-4.3 years) having modified Glenn- or Fontan-type surgery. The central lines were removed with a median of 1.4 days after insertion (range 0.7-8.2 days) for these older children, compared with a median of 4.2 days of age (range 0.3-19.3 days) for the 133 children <1 year of age. Retrospective chart review of nursing notes, progress notes, cardiology notes, discharge summaries, echocardiographic reports, and cardiac catheterization reports for all patients who received an upper body central venous line (internal jugular or subclavian) showed no definitive diagnosis of an upper body venous stenosis or thrombosis related to the central venous line. A further targeted review of echocardiographic and cardiac catheterization studies for univentricular cardiac patients failed to show stenosis or thrombosis of a vessel associated with upper body central line placement.
This study describes one institution's experience with routine upper body central venous catheter placement for neonatal and infant cardiac surgery as well as univentricular cardiac palliation (Glenn and Fontan procedures) with minimal risk of clinically significant catheter-associated vessel thrombosis or stenosis. No upper body central venous stenosis or thrombosis was detected in association with perioperative catheter placement in the upper body central venous system, primarily the right internal jugular vein in 156 cases. Right internal jugular central line placement for infant cardiac surgery can be utilized with a low risk of direct venous thrombosis or stenosis.
位于颈静脉或锁骨下静脉的中心静脉导管可为小儿心脏手术提供快速、可靠的血管通路。然而,血管内导管与血管损伤相关。上半身中心静脉的狭窄或血栓形成可导致“上腔静脉综合征”,使头颈部静脉压力显著升高,引起面部肿胀和头痛。对于接受上腔静脉肺动脉分流术(格林手术)或全腔静脉肺动脉连接术(Fontan手术)的患者,这种并发症可能尤为严重。作者推测上半身中心静脉置管导致静脉血栓形成或狭窄的风险较低。
对一家机构三年来的婴儿及单心室心脏手术进行回顾性研究。纳入2010年1月至2012年12月期间年龄小于1岁或5岁以下因单心室心脏解剖结构接受姑息治疗的235例连续心脏手术患者。在本研究机构,小儿心脏手术麻醉诱导后,麻醉医生常规放置上半身中心静脉导管。主要例外情况是已通过脐静脉或股静脉建立中心静脉通路。2岁以下患者使用4.0法国规格、5厘米长的双腔中心静脉导管[库克医疗聚氨酯材质,无抗生素或肝素涂层]。2岁以上患者使用5.0法国规格、8厘米长的三腔中心静脉导管[库克医疗聚氨酯材质,无抗生素或肝素涂层]。对病历、医院报告、超声心动图研究和心导管检查研究进行回顾性分析。
年龄小于1岁的婴儿和年龄小于5岁、功能单心室心脏的患者共计235例,接受了261次心脏手术。在这261例病例中,插入了171根4.0或5.0法国规格的上半身中心静脉导管。共放置了158根右颈内静脉导管。在未能成功获得右颈内静脉通路后,该人群中放置了2根左颈内静脉导管、2根左锁骨下静脉导管和9根右锁骨下静脉导管。由于样本量小(N = 13),未置于右颈内静脉的中心静脉导管被排除在进一步分析之外。2例右颈内静脉置管患者因置管期间死亡(无已知狭窄或血栓形成)被排除。在接受改良格林手术或Fontan手术、年龄超过1岁(1.1 - 4.3岁)的患者中放置了23根4.0或5.0法国规格的右颈内静脉中心静脉导管。这些大龄儿童的中心静脉导管在插入后中位1.4天(范围0.7 - 8.2天)拔除,而133例1岁以下儿童的中心静脉导管拔除中位年龄为4.2天(范围0.3 - 19.3天)。对所有接受上半身中心静脉置管(颈内静脉或锁骨下静脉)患者的护理记录、病程记录、心脏病学记录、出院小结、超声心动图报告和心导管检查报告进行回顾性图表分析,未发现与中心静脉导管相关的上半身静脉狭窄或血栓形成的确切诊断。对单心室心脏患者的超声心动图和心导管检查研究进行进一步针对性分析,未发现与上半身中心静脉置管相关的血管狭窄或血栓形成。
本研究描述了一家机构在新生儿及婴儿心脏手术以及单心室心脏姑息治疗(格林手术和Fontan手术)中常规放置上半身中心静脉导管的经验,导管相关的血管血栓形成或狭窄的临床显著风险极小。在上半身中心静脉系统(主要是156例右颈内静脉)围手术期置管未检测到上半身中心静脉狭窄或血栓形成。婴儿心脏手术中右颈内静脉中心静脉置管可采用,直接静脉血栓形成或狭窄风险较低。